You Asked: How Worrisome is the Boxed Warning for the New Postpartum Depression Medication?
The package insert advises patients to avoid driving and other potentially hazardous activities after taking zuranolone.
The package insert advises patients to avoid driving and other potentially hazardous activities after taking zuranolone.
There is evidence that depression itself can increase risk for hypertension and preeclampsia. Future studies will help to clarify the complex interaction between depression, SSRI treatment and pre-eclampsia.
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment.
Many women experience depression during pregnancy. What is the best way to identify these women?
The FDA will review zuranolone for the treatment of depression in the first half of 2022.
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment.
The reality is that most of the antidepressants taken by women today are relatively safe and carry a very low risk to the developing fetus.
While we have data to support the use of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs) and the serotonin norepinephrine reuptake inhibitors (SNRIs), during pregnancy, most studies have focused on risk of congenital [...]
Many women ask whether taking antidepressants may increase the risk for miscarriage or spontaneous abortion. Some, but not all, studies have demonstrated an increased risk of miscarriage among women who use antidepressants. However, it has [...]
While we have heard a lot about brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant – SAGE 217 or zuranolone – has been [...]